Correlation Between Bristol Myers and VistaGen Therapeutics
Can any of the company-specific risk be diversified away by investing in both Bristol Myers and VistaGen Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bristol Myers and VistaGen Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Bristol Myers Squibb and VistaGen Therapeutics, you can compare the effects of market volatilities on Bristol Myers and VistaGen Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bristol Myers with a short position of VistaGen Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bristol Myers and VistaGen Therapeutics.
Diversification Opportunities for Bristol Myers and VistaGen Therapeutics
-0.12 | Correlation Coefficient |
Good diversification
The 3 months correlation between Bristol and VistaGen is -0.12. Overlapping area represents the amount of risk that can be diversified away by holding Bristol Myers Squibb and VistaGen Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on VistaGen Therapeutics and Bristol Myers is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bristol Myers Squibb are associated (or correlated) with VistaGen Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of VistaGen Therapeutics has no effect on the direction of Bristol Myers i.e., Bristol Myers and VistaGen Therapeutics go up and down completely randomly.
Pair Corralation between Bristol Myers and VistaGen Therapeutics
Considering the 90-day investment horizon Bristol Myers Squibb is expected to generate 0.53 times more return on investment than VistaGen Therapeutics. However, Bristol Myers Squibb is 1.9 times less risky than VistaGen Therapeutics. It trades about 0.05 of its potential returns per unit of risk. VistaGen Therapeutics is currently generating about -0.04 per unit of risk. If you would invest 4,762 in Bristol Myers Squibb on November 9, 2024 and sell it today you would earn a total of 980.00 from holding Bristol Myers Squibb or generate 20.58% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Bristol Myers Squibb vs. VistaGen Therapeutics
Performance |
| Timeline |
| Bristol Myers Squibb |
| VistaGen Therapeutics |
Bristol Myers and VistaGen Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Bristol Myers and VistaGen Therapeutics
The main advantage of trading using opposite Bristol Myers and VistaGen Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bristol Myers position performs unexpectedly, VistaGen Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in VistaGen Therapeutics will offset losses from the drop in VistaGen Therapeutics' long position.| Bristol Myers vs. AbbVie Inc | Bristol Myers vs. Merck Company | Bristol Myers vs. Gilead Sciences | Bristol Myers vs. Johnson Johnson |
| VistaGen Therapeutics vs. Synlogic | VistaGen Therapeutics vs. AC Immune | VistaGen Therapeutics vs. Entera Bio | VistaGen Therapeutics vs. Tempest Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
Other Complementary Tools
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |